I would like to receive more information on the management of schizophrenia (select all that apply):

Please arrange a meeting with a specialist representative

I would be interested in an In-Practice Quality Use of Medicine education session with a mental health nurse team educator

I would like to learn more about the ATLAS Patient Support Program

I consent to receiving emails about new products, programs, services and educational events that can help me manage patients with schizophrenia

Name

Occupation

Doctor

Nurse

Other

Practice Address

For medical enquiries related to INVEGA TRINZA and INVEGA SUSTENNA, please contact Janssen Medical Information at medinfo@janau.jnj.com or call 1800 226 334.

PRIVACY POLICY: We collect your personal information such as your name, contact and professional details to manage our relationship with you and for our related administrative purposes. Without your personal information we are unable to provide this service. Your personal information may sometimes be disclosed to our contracted service providers and our affiliates based respectively in France and the USA who help us manage aspects of our IT and related data processing activities. These service providers are subject to contractual measures to safeguard and protect your personal information consistent with Australian privacy laws.

Subject to some exceptions permitted by law you may be able to request access to, or correction of, your personal information. For further information about how you might request access to or correct your personal information, make a privacy enquiry or complaint, to opt-out of receiving communications from us or to see our full Privacy Policy please go to www.janssen.com/australia/privacy

Janssen-Cilag Pty Ltd. ABN 47 000 129 975. 1–5 Khartoum Rd, Macquarie Park NSW 2113. Ph: 1800 226 334. CP-260694. JANS3861/EMBC. Date of preparation: September 2021.